Navidea Biopharmaceutica Pink Sheet Forward View - Triple Exponential Smoothing
| NAVBDelisted Stock | USD 0.0001 0.00 0.00% |
Navidea Pink Sheet outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Navidea Biopharmaceutica stock prices and determine the direction of Navidea Biopharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Navidea Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Navidea Biopharmaceutica's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Navidea Biopharmaceutica hype-based prediction, you can estimate the value of Navidea Biopharmaceuticals from the perspective of Navidea Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Navidea Biopharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00002 and the sum of the absolute errors of 0. Navidea Biopharmaceutica after-hype prediction price | USD 9.4E-5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Navidea |
Navidea Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine Navidea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Navidea using various technical indicators. When you analyze Navidea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Navidea Biopharmaceutica Triple Exponential Smoothing Price Forecast For the 19th of February
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Navidea Biopharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00002, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Navidea Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Navidea Biopharmaceutica's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Navidea Biopharmaceutica Pink Sheet Forecast Pattern
| Backtest Navidea Biopharmaceutica | Navidea Biopharmaceutica Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Navidea Biopharmaceutica pink sheet data series using in forecasting. Note that when a statistical model is used to represent Navidea Biopharmaceutica pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.1415 |
| SAE | Sum of the absolute errors | 0.0012 |
Predictive Modules for Navidea Biopharmaceutica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Navidea Biopharmaceutica. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Navidea Biopharmaceutica's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Navidea Biopharmaceutica After-Hype Price Density Analysis
As far as predicting the price of Navidea Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Navidea Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Navidea Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Navidea Biopharmaceutica Estimiated After-Hype Price Volatility
In the context of predicting Navidea Biopharmaceutica's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Navidea Biopharmaceutica's historical news coverage. Navidea Biopharmaceutica's after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Navidea Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Navidea Biopharmaceutica is out of control at this time. Analysis and calculation of next after-hype price of Navidea Biopharmaceutica is based on 3 months time horizon.
Navidea Biopharmaceutica Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Navidea Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Navidea Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Navidea Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
14.55 | 87.76 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.000094 | 6.43 |
|
Navidea Biopharmaceutica Hype Timeline
Navidea Biopharmaceutica is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Navidea is anticipated to decline in value after the next headline, with the price expected to drop to 9.4E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -6.43%, whereas the daily expected return is now at 14.55%. The volatility of related hype on Navidea Biopharmaceutica is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 35.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.39. Navidea Biopharmaceutica last dividend was issued on the 26th of April 2019. The entity had 1:20 split on the 26th of April 2019. Given the investment horizon of 90 days the next anticipated press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.Navidea Biopharmaceutica Related Hype Analysis
Having access to credible news sources related to Navidea Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict Navidea Biopharmaceutica's future price movements. Getting to know how Navidea Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Navidea Biopharmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GNBT | Generex Biotechnology Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WPDPF | WPD Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NNMX | Nanomix | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NMDBF | NeonMind Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GLSHQ | Gelesis Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MOSTQ | MobileSmith | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GDBYF | Goodbody Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CRXM | Taxus Cardium Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MGFRF | MagForce AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ACORQ | Acorda Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Navidea Biopharmaceutica Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Navidea Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of Navidea Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Navidea Biopharmaceutica by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Navidea Biopharmaceutica Market Strength Events
Market strength indicators help investors to evaluate how Navidea Biopharmaceutica pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Navidea Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Navidea Biopharmaceutica pink sheet market strength indicators, traders can identify Navidea Biopharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Navidea Biopharmaceutica Risk Indicators
The analysis of Navidea Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Navidea Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting navidea pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 14.81 | |||
| Standard Deviation | 52.16 | |||
| Variance | 2720.4 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Navidea Biopharmaceutica
The number of cover stories for Navidea Biopharmaceutica depends on current market conditions and Navidea Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Navidea Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Navidea Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Navidea Biopharmaceutica Short Properties
Navidea Biopharmaceutica's future price predictability will typically decrease when Navidea Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Navidea Biopharmaceuticals often depends not only on the future outlook of the potential Navidea Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Navidea Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.3 M | |
| Cash And Short Term Investments | 2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |